MannKind | 资产



Assets 更改 日
Adma Biologics USD 488.68M 98.06M 2024-12
Dynavax Technologies USD 945.93M 40.33M 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Halozyme Therapeutics USD 2.2B 133.06M 2025-03
Insmed USD 2.03B 27.74M 2024-12
MacroGenics USD 261.65M 2.84M 2024-12
MannKind USD 393.84M 70.36M 2024-12
Merck USD 115.12B 1.98B 2025-03
Novo Nordisk DKK 397.44B 28.06B 2024-09
Pfizer USD 208.03B 5.37B 2025-03
Sanofi 131.89B 906M 2025-03
Xencor USD 904.69M 47.26M 2025-03



MannKind 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.